Collect studies, extract structured data with AI, resolve reviewer disagreements, assess risk of bias, and build your synthesis in one workspace.
AI assists. Your team reviews and decides.We enrolled 124 patients aged 3–6 years from four community clinics and randomised them to 38% SDF or placebo varnish. Allocation was concealed using sequentially numbered opaque envelopes prepared by a statistician not involved in recruitment.
Children were eligible if they presented with at least one active carious lesion in a primary tooth.
“We enrolled 124 patients aged 3–6 years from four community clinics and randomised them to 38% SDF or placebo varnish.”
Reviewers enter values independently. Where they differ, the adjudicator sees every entry with its evidence, a majority suggestion when two agree, and records one decision.
Reviewers work through RoB 2 domains for parallel-group randomized trials with the supporting evidence visible, and resolve differences into a recorded assessment.
Map fields to outcomes and comparisons, confirm eligible studies, then pool with a forest plot and diagnostics, or synthesize without pooling when pooling is not appropriate.
Project owners define the scope and assign reviewer seats. Each reviewer sees the studies waiting on them; leads see progress across extraction, consensus and appraisal.
Records arrive from the sources review teams already use. What leaves carries the review with it: values with their source pages, judgements with their evidence, and plots with the study-level data behind them.